Meike Kasten, MD
Associate Professor Neuropsychiatric Epidemiology (Department of Psychiatry and Institute of Neurogenetics), W2 Professor
- University of Lübeck; Ratzeburger Allee 160, 23538 Lübeck, Germany
- +49 (0)451 3101 8230
- +49 (0)451 3101-8204
- meike.kasten@uni-luebeck.de
- https://www.neurogenetics-luebeck.de/
1996-2002 University of Bochum, Germany, Medical School
2002 Medical thesis
2002-2004 Residency in Neurology, Department of Neurology, University of Lübeck
2002-present Research work in the Institute of Neurogenetics, Lübeck with Prof. Christine Klein
2004-2006 Postdoctoral Research Fellow in Neuroepidemiology at the Parkinson’s Institute in Sunnyvale, California with Prof. Caroline Tanner
2006-2011 Residency in Psychiatry, Department of Psychiatry and Psychotherapy, University of Lübeck
2011-2013 Staff Physician, Department of Psychiatry and Psychotherapy and start of the working group of Neuropsychiatric Epidemiology
2012 Habilitation
7/2013-present W2 Professor in Neuropsychiatric Epidemiology at the Department of Psychiatry and Psychotherapy and the Institute of Neurogenetics, University of
Lübeck
2018-present After review of scientific work, permanent position as W2 Professor in Neuropsychiatric Epidemiology
2003 – present ad hoc reviewer for JNNP, Acta Neurologica Scandinavia, Deutsche Medizinische Wochenschrift, and Movement Disorders
2012 – present Editorial board of “biomedical research” and “datasets international”
2012 – present Mentor in the Mentoring program of the German Society of Psychiatry and Psychotherapy”
2014 Member of the “Berufungskommission” Psychology
2014 – present Mentor in the Mentoring program “women in leading positions” of the University of Lübeck
2014 – present Member of the “Promotionskommission” of the University of Lübeck
2004-2006 Stipend of the Michael J Fox Foundation
2005 Junior Scholarship Award of the Movement Disorder Society
2009 Travel Grant, Melvin Yahr Foundation
2011 Best Poster Awards, ‘Deutsche Gesellschaft für Neurologie’ and ‘Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde’
From 90 original publications; total citations: 6,933; h-index: 43
- Kasten M, Hagenah J, Graf J, Lorwin A, Vollstedt E-J, Peters E, Katalinic A, Raspe H, Klein C. Cohort Profile: A population-based cohort to study non-motor symptoms in parkinsonism (EPIPARK). Int J Epidemiology 2013;42:128-128k. [IF: 9.2]
- Lohmann K, Wilcox RA, Winkler S, Ramirez A, Rakovic A, Park J, Arns B, Lohnau T, Groen J, Kasten M, Brüggemann N, Hagenah J, Schmidt A, Kaiser F, Kumar KR, Zschiedrich K, Alvarez-Fischer D, Altenmüller E, Ferbert A, Lang AE, Münchau A, Kostic V, Simonyan K, Agzarian M, Ozelius LJ, Langeveld APM, Sue CM, Tijssen MAJ, Klein C. Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the ZUBB4 gene. Ann Neurol 2013;73:537-45. [IF: 11.9]
- Grünewald A, Kasten M (equally contributing first author), Ziegler A, Klein C. Next-Generation Phenotyping Using the Parkin Example: Time to Catch Up With Genetics. JAMA Neurol 2013;70:1186-91. [IF: 7.3]
- Furlong M, Tanner CM, Goldman SM, Bhudhikanok GS, Blair A, Chade A, Comyns K, Hoppin JA, Kasten M, Korell M, Langston JW, associations of specific pesticides with Parkinson’s disease. Environ Int 2015;75:144-50. [IF: 5.9]
- Kasten M, Klein C. Genetic risk loci for Parkinson’s disease: Moving from state to trait? Mov Disord 2015;30:747-749. [IF: 6.0]
- Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, Behnke S, Berendse HW, Bloem BR, Burn D, Dodel R, Grosset DG, Hu M, Kasten M, Krüger R, Moccia M, Mollenhauer B, Oertel W, Suenkel U, Walter U, Wirdefeldt K, Liepelt-Scarfone I, Maetzler W, Berg D. Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned. Front Aging Neurosci 2016;8:147. [IF: 4.5]
- Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt EJ, Balck A, Domingo A, Vulinovic F, Dulovic M, Zorn I, Madoev H, Zehnle H, Lembeck CM, Schawe L, Reginold J, Huang J, König IR, Bertram L, Marras C, Lohmann K, Lill CM, Klein C. Genotype-Phenotype Relations for the Parkinson’s Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review. Mov Disord 2018;33:730-741. [IF: 8.2]
- Vollstedt EJ, Kasten M, Klein C; MJFF Global Genetic Parkinson’s Disease Study Group. Using global team science to identify genetic parkinson’s disease worldwide. Ann Neurol 2019;86:153-157. [IF: 9.5]
- Olschewski L, Jesús S, Kim HJ, Tunc S, Löns S, Junker J, Zeuner KE, Kühn AA, Kuhlenbäumer G, Schäffer E, Berg D, Kasten M, Ferbert A, Altenmüller E, Brüggemann N, Bauer P, Rolfs A, Jeon B, Bäumer T, Mir P, Klein C, Lohmann K. Role of ANO3 mutations in dystonia: A large-scale mutational screening study. Parkinsonism Relat Disord 2019;62:196-200. [IF: 4.4]
- Grover S, Lill CM, Kasten M, Klein C, Del Greco M F, König IR. Risky behaviors and Parkinson disease: A mendelian randomization study. Neurology 2019 [epub ahead of print] [IF: 7.6]